FcBP-HFQ lipid-mediated trastuzumab modification of mRNA-loaded lipid nanoparticles enhances delivery to HER2-expressing cancer cells.

Matsumoto M, Takayama R, Matsuguchi C, Shimada H, Izumi T, Kato N, Matsuo-Tani A, Nakamura H, Hiu T, Matsuo T, Mukai H, Kawakami S

Open source

DOI: 10.1016/j.ejps.2026.107645
Published: 2026 Nov 1
Container: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejps.2026.107645,
  title = {FcBP-HFQ lipid-mediated trastuzumab modification of mRNA-loaded lipid nanoparticles enhances delivery to HER2-expressing cancer cells.},
  author = {Matsumoto M and Takayama R and Matsuguchi C and Shimada H and Izumi T and Kato N and Matsuo-Tani A and Nakamura H and Hiu T and Matsuo T and Mukai H and Kawakami S},
  year = {2026},
  journal = {European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences},
  doi = {10.1016/j.ejps.2026.107645},
  url = {https://doi.org/10.1016/j.ejps.2026.107645}
}

RIS

TY  - JOUR
TI  - FcBP-HFQ lipid-mediated trastuzumab modification of mRNA-loaded lipid nanoparticles enhances delivery to HER2-expressing cancer cells.
AU  - Matsumoto M
AU  - Takayama R
AU  - Matsuguchi C
AU  - Shimada H
AU  - Izumi T
AU  - Kato N
AU  - Matsuo-Tani A
AU  - Nakamura H
AU  - Hiu T
AU  - Matsuo T
AU  - Mukai H
AU  - Kawakami S
PY  - 2026
JO  - European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
DO  - 10.1016/j.ejps.2026.107645
UR  - https://doi.org/10.1016/j.ejps.2026.107645
ER  -

APA

M, M., R, T., C, M., H, S., T, I., N, K., A, M., H, N., T, H., T, M., H, M., & S, K. (2026). FcBP-HFQ lipid-mediated trastuzumab modification of mRNA-loaded lipid nanoparticles enhances delivery to HER2-expressing cancer cells.. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. https://doi.org/10.1016/j.ejps.2026.107645

Source records

pubmed · retrieved 2026-09-25T12:25:56.406Z
europe-pmc · retrieved 2026-09-25T12:25:57.508Z